LCN2 and pachyonychia congenita: Having examined the diagnostic performance of individual markers, we next sought to investigate whether adding either NGAL or MIC-1 to CA19-9 (the gold standard) improved the ability to distinguish PC cases (resectable or unresectable) from CP or HCs.